PURPOSE: To evaluate the capability of amide proton transfer (APT) MR imaging for detection of prostate cancer that typically shows a higher tumor cell proliferation rate and cellular density leading to an MRI-detectable overall elevated mobile protein level in higher grade tumors. MATERIALS AND METHODS: Twelve patients with biopsy-proven prostate cancer were imaged on a 3 Tesla MR imaging system before prostatectomy. APT-MR images were acquired by means of a single-slice single-shot turbo spin echo sequence with a saturation prepulse preparation using 33 different frequency offsets (-8 to 8 ppm, interval 0.5 ppm). For quantification we used the APT ratio (APTR) based on the asymmetry of the magnetization transfer ratio at 3.5 ppm in respect to the water signal. Tumor and peripheral zone benign regions of interest (ROIs) were delineated based on whole mount pathology slides after prostatectomy. RESULTS: APTR in prostate cancer ROIs was 5.8% ± 3.2%, significantly higher than that in the peripheral zone benign regions (0.3% ± 3.2%, P = 0.002). CONCLUSION: APT-MR imaging is feasible in prostate cancer detection and has the potential to discriminate between cancer and noncancer tissues.
PURPOSE: To evaluate the capability of amide proton transfer (APT) MR imaging for detection of prostate cancer that typically shows a higher tumor cell proliferation rate and cellular density leading to an MRI-detectable overall elevated mobile protein level in higher grade tumors. MATERIALS AND METHODS: Twelve patients with biopsy-proven prostate cancer were imaged on a 3 Tesla MR imaging system before prostatectomy. APT-MR images were acquired by means of a single-slice single-shot turbo spin echo sequence with a saturation prepulse preparation using 33 different frequency offsets (-8 to 8 ppm, interval 0.5 ppm). For quantification we used the APT ratio (APTR) based on the asymmetry of the magnetization transfer ratio at 3.5 ppm in respect to the water signal. Tumor and peripheral zone benign regions of interest (ROIs) were delineated based on whole mount pathology slides after prostatectomy. RESULTS: APTR in prostate cancer ROIs was 5.8% ± 3.2%, significantly higher than that in the peripheral zone benign regions (0.3% ± 3.2%, P = 0.002). CONCLUSION: APT-MR imaging is feasible in prostate cancer detection and has the potential to discriminate between cancer and noncancer tissues.
Authors: Vijay Shah; Thomas Pohida; Baris Turkbey; Haresh Mani; Maria Merino; Peter A Pinto; Peter Choyke; Marcelino Bernardo Journal: Rev Sci Instrum Date: 2009-10 Impact factor: 1.523
Authors: Jamie Near; Cesare Romagnoli; Andrew T Curtis; L Martyn Klassen; Jonathan Izawa; Joseph Chin; Robert Bartha Journal: J Magn Reson Imaging Date: 2009-08 Impact factor: 4.813
Authors: Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; John Trachtenberg; Brian C Wilson; Masoom A Haider Journal: J Magn Reson Imaging Date: 2009-08 Impact factor: 4.813
Authors: Guanshu Liu; M Meser Ali; Byunghee Yoo; Mark A Griswold; Jean A Tkach; Mark D Pagel Journal: Magn Reson Med Date: 2009-02 Impact factor: 4.668
Authors: Shu Zhang; Jochen Keupp; Xinzeng Wang; Ivan Dimitrov; Ananth J Madhuranthakam; Robert E Lenkinski; Elena Vinogradov Journal: Magn Reson Med Date: 2017-09-01 Impact factor: 4.668
Authors: Yee Kai Tee; Manus J Donahue; George W J Harston; Stephen J Payne; Michael A Chappell Journal: J Magn Reson Imaging Date: 2013-11-08 Impact factor: 4.813
Authors: Huajun She; Joshua S Greer; Shu Zhang; Bian Li; Jochen Keupp; Ananth J Madhuranthakam; Ivan E Dimitrov; Robert E Lenkinski; Elena Vinogradov Journal: Magn Reson Med Date: 2018-08-26 Impact factor: 4.668